Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy

[1]  Skorić Dejan,et al.  Vincristine induced unilateral ptosis. , 2009, Journal of pediatric hematology/oncology.

[2]  C. Ikonomidou,et al.  Treatment of Vincristin-induced bilateral Ptosis , 2008 .

[3]  A. O. Bayrak,et al.  PYRIDOXINE AND PYRIDOSTIGMINE TREATMENT IN VINCRISTINE-INDUCED NEUROPATHY , 2007, Pediatric hematology and oncology.

[4]  A. Oner,et al.  Vincristine induced cranial polyneuropathy , 2006, Indian journal of pediatrics.

[5]  O. Duman,et al.  Treatment of vincristine-induced cranial polyneuropathy. , 2005, Journal of pediatric hematology/oncology.

[6]  S. Uccini,et al.  Vincristine neuropathy: Neurophysiological and genetic studies in a case of Wilms tumor , 2004, Pediatric blood & cancer.

[7]  C. Kramm,et al.  Treatment of vincristine‐induced bilateral ptosis with pyridoxine and pyridostigmine , 2004, Pediatric blood & cancer.

[8]  J. Kurtzberg,et al.  Vincristine-Induced Neuropathy as the Initial Presentation of Charcot-Marie-Tooth Disease in Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study , 2003, Journal of pediatric hematology/oncology.

[9]  H. El-Solh,et al.  ENHANCED VINCRISTINE NEUROTOXICITY FROM DRUG INTERACTIONS: Case Report and Review of Literature , 2001, Pediatric hematology and oncology.

[10]  J. Riggs,et al.  Fulminant Peripheral Neuropathy with Severe Quadriparesis Associated with Vincristine Therapy , 2000, The Annals of pharmacotherapy.

[11]  Cohen Jd,et al.  Disorders of colonic motility in patients with diabetes mellitus. , 1983 .